any one of the modified amino acids disclosed in US 5,866,536 can particularly any one of compounds I to CXXIII, as disclosed in US 5,866,536 which is incorporated herein by reference, or a pharmaceutically acceptable salt or solvate thereof, such as a disodium salt, an ethanol solvate, or a hydrate of any one of these compounds any one of the modified amino acids disclosed in US 5,773,647 particularly any one of compounds 1 to 193, as disclosed in US 5,773,647 which is incorporated herein by reference, or a pharmaceutically acceptable salt or solvate thereof, such as a disodium salt, an ethanol solvate, or a hydrate of any one of these compounds any one of the modified amino acids disclosed in US 5,773,647 particularly any one of compounds 1 to 193, as disclosed in US 5,773,647 which is incorporated herein by reference, a complex lipoidal dispersion e.g., a combination of an insoluble surfactant or oil with a soluble surfactant, and optionally with water or a co-solvent exemplary permeation enhancers include, in particular, mixed micelles, reversed micelles, a self emulsifying system (e.g., SEDDS, SMEDDS, or SNEDDS), a lipid dispersion, a course emulsion, or solid lipid nanoparticles (SLNs)
This finding has implications for functional GI disorders, though it remains preclinical 10
Plasma half-life after parenteral injection in animal models is measured at under thirty minutes
Delta sleep-inducing peptide (DSIP) and its effects on neuroinflammation
Retinoids still have decades of independent trials behind them
